Bruce Donzanti

Senior Group Director, Global Pharmacovigilance Innovation Policy
Hoffmann-La Roche
Participe à 1 Session

Bruce has a PhD in pharmacology/neuroscience with almost 30 years of experience in the pharma/biotech industry. After serving in the US Army, he entered academics where he performed research on mechanisms of neuronal degeneration and neurotoxicology. He continued his pre-clinical research in industry before moving into clinical development and eventually Medical Affairs. Bruce has held various positions in industry, including Head of Drug Safety at Genentech and now Senior Group Director of Pharmacovigilance Innovation Policy in Regulatory Affairs. In this role over the past 2 plus years, Bruce has been working with key industry and health authority stakeholders to focus on new AI methodologies for pharmacovigilance and clinical trials.

Sessions auxquelles Bruce Donzanti participe

jeudi 21 novembre, 2019

9h15
9h15
  • L'IA au Canada : Une puissance à explorer
  • Inscription req.
  • Académie A et B
  •  3 heures 15 minutes
  • SymposiumVirage technologique et intelligence artificielle